Physician profile
Robert Patrick Collette
NPI 1659332732
$2,624.53
in general payments reported to CMS, 2019-2025
14 companies · $44.33 in 2025
The $44.33 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $1,479 · 2021: $199 · 2022: $505 · 2023: $138 · 2024: $70.77 · 2025: $44.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,268.46 | 2020 | |
| Acclarent, INC | $295.13 | 2019-2020 | |
| Glaxosmithkline, LLC. | $265.62 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $173.91 | 2021-2024 | Dupixent |
| Genzyme Corporation | $146.89 | 2021-2022 | |
| Depuy Synthes Sales INC. | $130.04 | 2022 | |
| Stryker Corporation | $119.91 | 2019-2022 | |
| Intersect Ent, INC. | $76.92 | 2019-2022 | |
| Aerin Medical INC. | $37.62 | 2022-2025 | |
| Smith+Nephew, INC. | $32.30 | 2021-2024 | Rf20000, Halo |
| Merck Sharp & Dohme LLC | $23.95 | 2023 | |
| Photonicare INC | $22.71 | 2023 | Otosight Middle Ear Scope |
| Cook Medical LLC | $18.07 | 2021 | |
| Optinose US, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Collette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.